BSE · 531043
Dhanvantri Jeevan Rekha Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹23 Cr with net profit ₹1 Cr — a 2.19% net margin, versus 0.8% the period before.
Shareholding
As of 2026-06-30
- Promoter19.65%
- Public80.35%
1,688 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.84× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #55 of 79 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,29,234 Cr | 244.11 | 13.63 | 20.48% | 7.7% |
| Max Healthcare Institute Ltd. | ₹1,09,470 Cr | 73.81 | 10.19 | 13.42% | 17.23% |
| Fortis Healthcare Ltd. | ₹71,634 Cr | 269.56 | 7.24 | 10.53% | 11.41% |
| Narayana Hrudayalaya Ltd. | ₹42,513 Cr | 50.7 | 9.37 | 17.76% | 10.2% |
| Aster DM Healthcare Ltd. | ₹42,038 Cr | 298.29 | 9.19 | 8.48% | 8.36% |
| Global Health Limited | ₹38,082 Cr | 264.25 | 9.61 | 14.05% | 12.62% |
| Krishna Institute of Medical Sciences Ltd. | ₹33,895 Cr | 136.55 | 9.04 | 10.74% | 6.18% |
| Dr. Lal Path Labs Ltd. | ₹31,496 Cr | 239.03 | 12.55 | 20.13% | 18.27% |
| Poly Medicure Ltd. | ₹16,888 Cr | 51.6 | 5.44 | 10.37% | 17.18% |
| Rainbow Childrens Medicare Ltd. | ₹15,420 Cr | 62.33 | 9.24 | 16.89% | 16.34% |
| Dhanvantri Jeevan Rekha Limited(this company) | ₹10 Cr | 26.02 | 1 | 3.81% | 1.51% |
AI analysis
AI-generated · google/gemini-2.5-flashDhanvantri Jeevan Rekha Limited is listed on the Indian markets with a market capitalization of Rs 12 Cr. The company has a Price-to-Earnings (PE) ratio of 28.78 and an Earnings Per Share (EPS) of 0.98. The book value is Rs 25.52. The Return on Equity (ROE) stands at 380.59% and Return on Capital Employed (ROCE) at 3.4965%.
Positives
- +Dhanvantri Jeevan Rekha Limited has a debt-to-equity ratio of 0, indicating no debt.
- +The Return on Equity (ROE) is 380.59%, which is high.
- +The net profit increased to Rs 0.51 Cr in Mar 2025 from Rs 0.17 Cr in Mar 2024.
Negatives
- −Promoter holding decreased from an unspecified amount to 19.65% as of June 30, 2026.
- −The Return on Capital Employed (ROCE) is 3.50%, which is relatively low.
- −The company's net profit has been inconsistent, reporting losses in Mar 2021 (-Rs 1.42 Cr) and Mar 2023 (-Rs 0.22 Cr).
Financial performance
The company's revenue increased to Rs 23.06 Cr in Mar 2025 from Rs 20.76 Cr in Mar 2024. Net profit also rose to Rs 0.51 Cr in Mar 2025 from Rs 0.17 Cr in Mar 2024. Earnings Per Share (EPS) for Mar 2025 was Rs 1.6, up from Rs 0.4 in Mar 2024.
Profitability & returns
The company reported a Return on Equity (ROE) of 380.59% and a Return on Capital Employed (ROCE) of 3.4965%. The profit margin for the company is 150.81%. The annual net profit was Rs 0.51 Cr in Mar 2025. Over the last five years, net profit has fluctuated, with a loss of Rs 1.42 Cr in Mar 2021 and a gain of Rs 0.51 Cr in Mar 2025.
Balance sheet
Dhanvantri Jeevan Rekha Limited has a debt-to-equity ratio of 0, indicating no debt. The book value per share is Rs 25.52. No further details regarding assets or liabilities are available.
Ownership & pledges
As of June 30, 2026, the promoter holding in Dhanvantri Jeevan Rekha Limited is 19.6474%. The public holds 80.3526% of the shares. There is no reported promoter pledge. The number of shareholders as of June 30, 2026, is 1688.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Dhanvantri Jeevan Rekha Limitedshare price & fundamentals